How to cite item

Real-world effectiveness and safety of adebrelimab as first-line treatment in patients with extensive-stage small cell lung cancer

   
@article{TLCR116528,
	author = {Tangfeng Lv and Bi Chen and Wei Chen and Yanmin Wu and Haitao Fei and Surong Fang and Lingfeng Min and Chong Li and Shuhua Han and Zhitong Zuo and Shencun Fang and Yahui Shen and Fenhong Qian and Bo Shen and Haitao Zhang and Ruifeng Zhang and Hui Liu and Lifeng Wang and Yong Song},
	title = {Real-world effectiveness and safety of adebrelimab as first-line treatment in patients with extensive-stage small cell lung cancer},
	journal = {Translational Lung Cancer Research},
	volume = {15},
	number = {4},
	year = {2026},
	keywords = {},
	abstract = {Extensive-stage small cell lung cancer (ES-SCLC) is a highly aggressive malignancy. Although immune checkpoint inhibitors (ICIs) combined with chemotherapy have become standard first-line therapy, real-world evidence is necessary to validate clinical trial findings. This study aimed to evaluate the real-world effectiveness and safety of adebrelimab-based therapy in Chinese patients with ES-SCLC.},
	issn = {2226-4477},	url = {https://tlcr.amegroups.org/article/view/116528}
}